Sort   by:  
 Page size 
UnknownMolecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial.
Not available
S-EPMC5078968 | biostudies-literature
UnknownTumor and germline next generation sequencing in high grade serous cancer: experience from a large population-based testing program.
Not available
S-EPMC7782089 | biostudies-literature
UnknownLandscape of genomic alterations in high-grade serous ovarian cancer from exceptional long- and short-term survivors.
Not available
S-EPMC6208125 | biostudies-literature
UnknownCD103+CD56+ ILCs Are Associated with an Altered CD8+ T-cell Profile within the Tumor Microenvironment.
Not available
S-EPMC11962407 | biostudies-literature
UnknownThe predictive value of nadir neutrophil count during treatment of cervical cancer: Interactions with tumor hypoxia and interstitial fluid pressure (IFP).
Not available
S-EPMC5862663 | biostudies-literature
UnknownAvoidance of apoptotic death via a hyperploid salvage survival pathway after platinum treatment in high grade serous carcinoma cell line models.
Not available
S-EPMC6877103 | biostudies-literature
UnknownIdentification of antigenic epitopes recognized by tumor infiltrating lymphocytes in high grade serous ovarian cancer by multi-omics profiling of the auto-antigen repertoire.
Not available
S-EPMC10264507 | biostudies-literature
UnknownA phase I study of the combination of ro4929097 and cediranib in patients with advanced solid tumours (PJC-004/NCI 8503).
Not available
S-EPMC3749563 | biostudies-literature
UnknownDeveloping a prognostic micro-RNA signature for human cervical carcinoma.
Not available
S-EPMC4399941 | biostudies-literature
UnknownNovel combinations of PI3K-mTOR inhibitors with dacomitinib or chemotherapy in PTEN-deficient patient-derived tumor xenografts.
Not available
S-EPMC5689564 | biostudies-literature
Sort   by:  
 Page size